IP Library Granted Patent US 8,124,393
Granted Patent B2
US 8,124,393 · App. 13/020,871 · Granted Feb 28, 2012

Compositions and methods for inducing or inhibiting activities of selected human cells

Assignees: St. Jude Children's Research Hospital; The University of North Carolina
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,124,393
App. No.
13/020,871
Granted
Feb 28, 2012
Kind
B2
Abstract

Polynucleotides encoding a mutant human carboxylesterase enzyme and polypeptides encoded by the polynucleotides which are capable of metabolizing a prodrug and inactive metabolites thereof to active drug are provided. Compositions and methods for sensitizing cells to a prodrug agent, inhibiting cell growth, treating drug addiction, and facilitating the metabolism of an organophosphate with this enzyme are also provided. In addition, a screening assay for identification of drugs activated by this enzyme is described.

Claims (8)

1. An isolated polypeptide as set forth in SEQ ID NO:3.

2. A method of inhibiting tumor recurrence in a patient comprising:

(a) surgically removing a tumor from a patient;

(b) administering the polypeptide of claim 1 at the site of tumor resection; and

(c) administering a chemotherapeutic prodrug systemically so that tumor recurrence is inhibited.

3. The method of claim 2 , wherein the chemotherapeutic prodrug is CPT-11.

4. A method for treating drug addiction comprising administering to a subject in need of treatment an effective amount of the polypeptide of claim 1 thereby treating the subject's drug addiction.

5. A method for facilitating the metabolism of an organophosphate comprising administering to a subject having been exposed to an organophosphate an effective amount of the polypeptide of claim 1 thereby facilitating the metabolism of the organophosphate.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 18, 2019
From: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048944/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2011
From: REDINBO, MATTHEW R.; POTTER, PHILIP M.; WEIRDL, MONIKA
To: THE UNIVERSITY OF NORTH CAROLINA; ST. JUDE CHILDREN'S RESEARCH HOSPITAL
Reel/Frame 025744/0334 →
Continuity (3)
Division 12306031
Provisional Application 60805643 · Jun 23, 2006
Related Publication 20110165141A1 · Jul 7, 2011